EWM
Essex Woodlands Management Portfolio holdings
AUM
$279M
This Quarter Return
+31.18%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$553M
AUM Growth
+$553M
(+26%)
Cap. Flow
-$3.28M
Cap. Flow
% of AUM
-0.59%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Ligand Pharmaceuticals
LGND
|
$3.28M |
Sector Composition
| 1 | Healthcare | 97.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
1
DELISTED
Abiomed Inc
ABMD
| $208M | 37.57% | 1,450,000 | – | – |
|
|
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
| $121M | 21.92% | 4,592,047 | – | – |
|
3
Axogen
AXGN
$743M
| $81.4M | 14.72% | 4,861,111 | – | – |
|
|
CORI
4
DELISTED
Corium International, Inc.
CORI
| $69.8M | 12.62% | 9,353,304 | – | – |
|
|
ENTL
5
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $53.5M | 9.68% | 3,231,656 | – | – |
|
|
ELGX
6
DELISTED
Endologix Inc
ELGX
| $11.7M | 2.12% | 1,257,468 | – | – |
|
7
MediciNova
MNOV
$64.3M
| $6.16M | 1.11% | 1,170,370 | – | – |
|
|
ACUR
8
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $1.1M | 0.2% | 1,956,397 | – | – |
|
9
Gyre Therapeutics
GYRE
$703M
| $372K | 0.07% | 78,622 | – | – |
|
|
10
Ligand Pharmaceuticals
LGND
$3.15B
| – | – | -30,996 | Closed | -$3.28M |
|